Global Research Antibodies Analysis Report 2024: A $3.5 Billion Market in 2022 - Historical Revenue Data for 2020-2022, Estimated Figures for 2023, and CAGR Forecasts through 2028

News provided by

Jan 17, 2024, 14:00 ET

DUBLIN, Jan. 17, 2024 /PRNewswire/ -- The "Global Markets for Research Antibodies" report has been added to ResearchAndMarkets.com's offering.

The global market for research antibodies was valued at approximately $3.5 billion in 2022. Among product segments, the primary antibody segment accounted for the highest market share in the global market for research antibodies in 2022. The primary antibody segment recorded $2.4 billion in revenue in 2022, and this segment is expected to grow at a CAGR of 9.7% during the forecast period.

This study focuses on the market side of research antibodies, as opposed to the technical side. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

The high growth rate of this segment is attributed to such factors as demand of antibodies research, the COVID- 19 pandemic, other infectious diseases and an increase in R&D activities by key companies to emerge with new antibodies to counter the global rise in different infectious diseases (e.g., HIV, malaria,dengue).

The advancement of biological discoveries will result in the need for more molecular targets to be detected by their antibodies. Antibodies for each of its many forms of post-translational modifications are needed, even for the same protein molecule. This is likely to propel the growth of the market for research antibodies during the forecast period.

Primary antibodies are used alone or in combination with a secondary antibody. Primary antibodies conjugated to fluorochromes are used in flow cytometry, whereas in microscopy, a primary-secondary antibody combination is used to increase the signal.

According to the Antibiotic.com, one supplier of antibodies states that primary antibodies can be used against any antigen, including proteins, peptides, carbohydrates and other small molecules. Primary antibodies can also be raised to recognize post-translational modifications, such as phosphorylation, acetylation, methylation and glycosylation. The supplier therefore offers more than 50,000 unconjugated and directly conjugated primary antibodies directed against more than 14,000 targets.

The secondary antibody segment is expected to grow at a CAGR of 7.8% during the forecast period. A rise in basic or clinical research to detect specific cell or tissue components (antigens), a shorter assay time, an increase in the versatility, antigen signal detection and amplification are likely to fuel the segment's growth in the next few years.

This report segments the global market for research antibodies based on type of antibody, clonality, host, major reactivities, application, end user and region.

Report Includes

In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
Evaluation of the current market size and revenue growth prospects specific to research antibodies, accompanied by a comprehensive market share analysis categorized by product, clonality, application, major reactivities, host species, end-user, and geographical region
Discussion on the factors affecting the companies' market shares, the current strategies of antibody companies, the effect of research funding, and the third-party quality evaluation systems of research antibodies
Description of antibody technologies, emerging antibody generation technologies and identification of market drivers, restraints and other forces impacting the global market
Discussion on technological trends in antibody production and application, and information on antibody-based drug discovery and development process
Impact analysis of COVID-19 on entire pharma industry and discussion on how COVID-19 is related to pharmaceutical industry's growth slow-down and results in delayed approvals for non-COVID-19-related pharmaceutical/biotech products
Coverage of new discoveries in biological sciences, rapid technological developments in the IVD industry, new antibody technologies and antibody types, and assessment of antibody-based drug discovery and development
Discussion on advantages and disadvantages of antibody discovery technologies with examples of antibody production, and information on REpAb technology
Coverage of FDA and international regulations, details of recent regulatory reforms and list of antibody therapeutics granted in 2018 and insights into government initiatives and funding in emerging markets
Examination of environmental, social, and corporate governance (ESG) developments, a relevant patent analysis; and merger and acquisitions (M&A), venture fundings, and emerging technologies in the global research antibodies

Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including

Abcam Plc
Absolute Antibody Ltd.
Agilent Technologies Inc.
Bd Biosciences
Bio-Rad (Abd Serotec)
Bio-Techne
Cell Signaling Technology Inc.
Danaher
Jackson Immunoresearch Laboratories Inc.
Lonza
Merck Kgaa (Sigma-Millipore)
Rockland Immunochemicals Inc.
Santa Cruz Biotechnology Inc.
Sino Biological Inc.
Thermo Fisher Scientific Inc.
United States Biological

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Introduction
History and Current State
Background of the Antibody and Its Production
Current Status and Issues
Overview of Antibody Technology
Traditional Antibody Generation Technologies
Antibody Generation Technologies
Antibody Validation Methods
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Journal Citations Analysis
Technological Trends in Antibody Production and Application

Chapter 4 Research Antibodies

Enzyme-Linked Immunosorbent Assay/Enzyme-Linked Immunosorbent Spot
Direct ELISA
Indirect ELISA
Competitive ELISA
Sandwich ELISA
ELISPOT Assays
FluoroSpot Assays
Emerging Technologies or Platforms in ELISA
Western Blot
One-Dimensional Gel Electrophoresis
Two-Dimensional Gel Electrophoresis
Emerging Technologies and Platforms in Western Blot
Immunohistochemistry
Multiplexed Staining
Low-Flexed Staining
Flow Cytometry
Emerging Technologies/Platforms in Flow Cytometry
Immunocytochemistry and Immunofluorescent Staining
Chromatin Immunoprecipitation
Other Antibody Applications
Antibody Arrays

Chapter 5 Market Dynamics

Market Drivers
New Discoveries in Biological Sciences
Rapid Technological Developments in the In Vitro Diagnostic Industry
New Antibody Technologies and Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
Need for Quality Antibodies in the Current Research Community
Need for Antibody Custom Services
New Application-Focused Technology Platforms
Market Restraints
Limited Research Funding
Low Validation Technologies
Decline in Suppliers
Decrease in Market Acceptance or Brand Trust
Market and Economic Risk
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Research Antibodies

Chapter 6 Market Breakdown by Type of Antibody

Global Market for Research Antibodies by Type
Primary Antibodies
Secondary Antibodies

Chapter 7 Market Breakdown by Clonality

Global Market for Research Antibodies by Clonality
Polyclonal Antibodies
Monoclonal Antibodies
Recombinant Antibodies

Chapter 8 Market Breakdown by Major Reactivity

Global Market for Research Antibodies by Major Reactivity
Human (Anti-Human)
Mouse (Anti-Mouse)
Rat (Anti-Rat)
Others

Chapter 9 Market Breakdown by Application

Global Market for Research Antibodies by Application
Western Blot
Flow Cytometry
Immunohistochemistry
Immunocytochemistry
Immunofluorescent Staining
Immunoprecipitation
ELISA

Chapter 10 Market Breakdown by Host Species

Global Market for Research Antibodies by Host Species
Rabbit Host Species
Goat Host Species
Mouse-Host Species
Sheep Host Species
Donkey Host Species
Other Host Species

Chapter 11 Market Breakdown by End User

Global Market for Research Antibodies by End User
Universities and Academic Institutions
Pharma and Biotech Companies
Other End Users

Chapter 12 Market Breakdown by Region

Chapter 13 Sustainability in the Research Antibodies Industry: An Environment, Social and Governance Sustainability in the Research

Importance of Environment, Social and Governance in the Research Antibodies Manufacturing Industry
Environment, Social and Governance Ratings and Metrics: Understanding the Data
Environmental, Social and Governance Practices in the Research Antibodies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Studies
Publisher Viewpoint

Chapter 14 Emerging Technology for Antibody Discovery and Generation

Traditional Antibody Discovery and Generation Technologies
Animal Plasma Isolation
Hybridoma Generation
B Cell Screening
Display Technologies
Emerging Antibody Discovery and Generation Technologies
Emerging Trends in the Antibody Production Technologies
Polyclonal Antibody Sequencing
Single B Cell Sequencing
Machine Learning-Assisted Discovery and Generation
Advantages and Disadvantages of Antibody Discovery Technol0gies
Examples of Antibody Production and Technologies
REpAb Technology
Boehringer Ingelheim's Partnership with Company
COVID-19 Vaccines by EABR Technology
First Therapeutic Antibody
Challenges and Future Research Direction

Chapter 15 Approved Monoclonal Antibodies, 2018-2023

Chapter 16 M&A and Venture Funding Outlook

Mergers and Acquisitions Analysis
Merger and Acquisition Deals: 2018-2023

Chapter 17 Competitive Landscape

Global Company Market Ranking
Distribution of the WHO's International Standard for Anti-SARS-CoV-2 Immunoglobulin
Top 100 Antibodies by Major Key Companies

For more information about this report visit https://www.researchandmarkets.com/r/82xjca

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets